Trial
NCT05959707
Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants
Phase ISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
HIV Vaccine Trials Network
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
HIV Infections
Intervention
VRC01.23LS
Why stopped
Mild Adverse Event related to VRC01.23LS administration was reported.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-05